IP Library Granted Patent US 11,541,015
Granted Patent B2
US 11,541,015 · App. 16/614,229 · Granted Jan 3, 2023

Self-righting systems, methods, and related components

Inventors: Carlo Giovanni Traverso (Newton, MA); Alex G. Abramson (St. Louis, MO); Ester Caffarel Salvador (Cambridge, MA); Niclas Roxhed (Cambridge, MA); Minsoo Khang (Boston, MA); Taylor Bensel (Walpole, MA); Robert S. Langer (Newton, MA)
Assignees: Massachusetts Institute of Technology; The Brigham and Women's Hospital, Inc.
A61K9/4808A61M5/1454A61M5/14276A61M5/158A61M37/0015A61M37/0069A61B10/06A61M2005/1581A61M2005/1585A61M2037/0023A61M2205/0238A61M2205/21A61M2210/106
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,541,015
App. No.
16/614,229
Granted
Jan 3, 2023
Kind
B2
Abstract

Self-righting articles, such as self-righting capsules for administration to a subject, are generally provided. In some embodiments, the self-righting article may be configured such that the article may orient itself relative to a surface (e.g., a surface of a tissue of a subject). The self-righting articles described herein may comprise one or more tissue engaging surfaces configured to engage (e.g., interface with, inject into, anchor) with a surface (e.g., a surface of a tissue of a subject). In some embodiments, the self-righting article may have a particular shape and/or distribution of density (or mass) which, for example, enables the self-righting behavior of the article. In some embodiments, the self-righting article may comprise a tissue interfacing component and/or a pharmaceutical agent (e.g., for delivery of the active pharmaceutical agent to a location internal of the subject). In some cases, upon contact of the tissue with the tissue engaging surface of the article, the self-righting article may be configured to release one or more tissue interfacing components. In some cases, the tissue interfacing component is associated with a self-actuating component. For example, the self-righting article may comprise a self-actuating component configured, upon exposure to a fluid, to release the tissue interfacing component from the self-righting article. In some cases, the tissue interfacing component may comprise and/or be associated with the pharmaceutical agent (e.g., for delivery to a location internal to a subject).

Claims (57)

1. A self-righting article, comprising:

a tissue interfacing component and a spring associated with the tissue interfacing component, the spring maintained by a support material under at least 5% compressive strain,

wherein the self-righting article has a largest cross-sectional dimension of less than or equal to 2 cm, and

wherein the self-righting article is a monostatic body due to a center of mass of the article and/or a shape of the article, such that the article has a single stable resting position.

2. A self-righting article as in claim 1 , wherein the spring is configured to release at least 10% of a stored compressive energy of the spring within 10 minutes of exposing the support material to a fluid.

3. A self-righting article as in claim 1 , wherein the self-righting article has a self-righting time from 90 degrees in water of less than or equal to 0.05 seconds.

4. A self-righting article as in claim 1 , wherein the tissue interfacing component comprises a pharmaceutical agent in an amount of greater than or equal to 10 wt % versus a total weight of the tissue interfacing component weight.

5. A self-righting article as in claim 1 , wherein the self-righting article has a monostatic shape.

6. A self-righting article as in claim 1 , wherein the self-righting article comprises a first portion and a second portion, the first portion having a different mass than the second portion.

7. A self-righting article as in claim 6 , wherein a ratio of a mass of the first portion and a mass of the second portion is greater than or equal to 1:1 and less than or equal to 10:1.

8. A self-righting article as in claim 6 , wherein an average density of the second portion is less than or equal to 2 g/mL and greater than or equal to 0.01 g/mL.

9. A self-righting article as in claim 6 , wherein an average density of the first portion is less than or equal to 20 g/mL and greater than or equal to 2 g/mL.

10. A self-righting article as in claim 1 , wherein the self-righting article is configured and arranged to be encapsulated within a capsule.

11. A self-righting article as in claim 1 , wherein the self-righting article comprises a coating on a least a portion of an outer surface of the self-righting article.

12. A self-righting article as in claim 1 , wherein the tissue interfacing component is selected from the group consisting of needles, biopsy punches, a jet injection component, and microneedles.

13. A self-righting article as in claim 1 , wherein, upon administration to a subject, the tissue interfacing component aligns within 15 degrees of orthogonal with a tissue internal to the subject.

14. A self-righting article as in claim 1 , wherein the self-righting article comprises one or more vents.

15. A self-righting article as in claim 1 , wherein the support material is configured to release the spring from compressive strain upon exposure to physiologic fluids.

16. A self-righting article, comprising:

a tissue interfacing component and a spring associated with the tissue interfacing component, the spring maintained by a support material under at least 5% compressive strain,

wherein the self-righting article has a largest cross-sectional dimension of less than or equal to 2 cm, and

wherein the self-righting article has a self-righting time from 90 degrees in water of less than or equal to 0.05 seconds.

17. A self-righting article as in claim 16 , wherein the self-righting article is a monostatic body due to a center of mass of the self-righting article and/or shape of the self-righting article, such that the self-righting article has a single stable resting position.

18. An article for delivering a pharmaceutical agent to a subject, comprising:

a tissue interfacing component; and

a spring associated with the tissue interfacing component and maintained by a support material under at least 5% compressive strain,

wherein the tissue interfacing component comprises a solid pharmaceutical agent in an amount of greater than or equal to 10 wt % versus a total weight of the tissue interfacing component, and

wherein the self-righting article is a monostatic body due to a center of mass of the article and/or a shape of the article, such that the article has a single stable resting position.

19. An article as in claim 18 , wherein the spring is configured to release at least 90% of a stored compressive energy of the spring within 10 minutes of exposing the support material to a fluid.

20. An article as in claim 18 , wherein the tissue interfacing component is a needle.

21. An article as in claim 18 , wherein the tissue interfacing component has a Young's elastic modulus of greater than or equal to 100 MPa.

22. An article for delivering a pharmaceutical agent to a subject, comprising:

a tissue interfacing component; and

a spring associated with the tissue interfacing component,

wherein the tissue interfacing component comprises a solid pharmaceutical agent in an amount of greater than or equal to 80 wt % versus a total weight of the tissue interfacing component, and

wherein the spring is configured to release at least 10% of a stored compressive energy of the spring within 10 minutes of exposing the support material to a fluid, and

wherein the self-righting article is a monostatic body due to a center of mass of the article and/or a shape of the article, such that the article has a single stable resting position.

23. An article as in claim 22 , wherein the spring is maintained by a support material under at least 5% compressive strain.

24. A self-righting article comprising,

one or more tissue interfacing components,

wherein the self-righting article has a self-righting time from 90 degrees in water of less than or equal to 0.05 seconds, and

wherein the self-righting article is configured such that the one or more tissue interfacing components has a longest longitudinal axis oriented within 15 degrees of vertical upon self-righting.

25. A self-righting article as in claim 24 , wherein the self-righting article is a monostatic body due to a center of mass of the article and/or a shape of the self-righting article, such that the self-righting article has a single stable resting position.

26. A self-righting article comprising,

a tissue interfacing component,

wherein the tissue interfacing component comprises a solid pharmaceutical agent in an amount of greater than or equal to 10 wt % versus a total weight of the tissue interfacing component weight, and

wherein the self-righting article is a monostatic body due to a center of mass of the article and/or a shape of the article, such that the article has a single stable resting position.

27. A method of delivering a pharmaceutical agent to a subject, comprising:

administering, to the subject, an article comprising a tissue interfacing component associated with the pharmaceutical agent; and

releasing, at a location internal to the subject, at least a portion of the pharmaceutical agent from the article,

wherein the article is a monostatic body due to a center of mass of the article and/or a shape of the article, such that the article has a single stable resting position,

wherein, upon reaching a location internal to the subject, the article:

has a longitudinal axis configured to orient to about 90 degrees with respect to vertical; and/or

can penetrate mucosal tissue with a force of greater than or equal to 1 mN and less than or equal to 20,000 mN; and/or

comprises a solid pharmaceutical agent in an amount of greater than or equal to 10 wt % a total weight of the tissue interfacing component; and/or

comprises a spring configured for instantaneous release.

28. A method as in claim 27 , wherein the article has an average density greater than 1 g/cm 3 .

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 16, 2020
From: TRAVERSO, CARLO GIOVANNI
To: MASSACHUSETTS INSTITUTE OF TECHNOLOGY; THE BRIGHAM AND WOMEN'S HOSPITAL, INC.
Reel/Frame 051533/0014 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 16, 2020
From: ABRAMSON, ALEX G.; CAFFAREL SALVADOR, ESTER; ROXHED, NICLAS; KHANG, MINSOO; BENSEL, TAYLOR; LANGER, ROBERT S.
To: MASSACHUSETTS INSTITUTE OF TECHNOLOGY
Reel/Frame 051620/0185 →
Continuity (4)
Provisional Application 62507665 · May 17, 2017
Provisional Application 62507647 · May 17, 2017
Provisional Application 62507653 · May 17, 2017
Related Publication 20220080115A1 · Mar 17, 2022
Cited By (2)
US 12,268,832 US 12,678,605